(NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and ...
QIAGEN is also introducing the QIAGEN Discovery Platform, which enables the integration of AI with QIAGEN’s biomedical ...
Ratio of Serum Transthyretin to NT-proBNP is a Novel Prognostic Measure for Transthyretin Amyloid Cardiomyopathy: Insights ...
BridgeBio will present the effects of encaleret on patient-reported outcomes and on bone turnover from the Phase 3 CALIBRATE trial. In partnership with the HypoPARAthyroidism Association, BridgeBio ...
BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO to Examine What it Takes to Turn Scientific Advancements ...
LANSING, Mich.-- (BUSINESS WIRE)--Neogen ® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, ...
Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the ...
Venture capital continued to flow into biopharma in the third quarter, though experts pointed out that investors remained ...
Premier's Innovation Celebration is entering its 15th year of recognizing and honoring healthcare supplier innovation. More ...
Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and ...
Series B funding will strengthen Multiply Labs' momentum scaling the robotic manufacturing platform turning AI-discovered drugs into treatments patients can receive.
The stock option will vest over a four-year period, with 25% of the option vesting on the first anniversary of such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results